The DOI matches its Crossref record; 207 of the 207 references it cites were found in a registry or an index.
ATP as a multi-target danger signal in the brain
Open accessAbstract
ATP is released in an activity-dependent manner from different cell types in the brain, fulfilling different roles as a neurotransmitter, neuromodulator, in astrocyte-to-neuron communication, propagating astrocytic responses and formatting microglia responses. This involves the activation of different ATP P2 receptors (P2R) as well as adenosine receptors upon extracellular ATP catabolism by ecto-nucleotidases. Notably, brain noxious stimuli trigger a sustained increase of extracellular ATP, which plays a key role as danger signal in the brain. This involves a combined action of extracellular ATP in different cell types, namely increasing the susceptibility of neurons to damage, promoting astrogliosis and recruiting and formatting microglia to mount neuroinflammatory responses. Such actions involve the activation of different receptors, as heralded by neuroprotective effects resulting from blockade mainly of P2X7R, P2Y1R and adenosine A2A receptors (A2AR), which hierarchy, cooperation and/or redundancy is still not resolved. These pleiotropic functions of ATP as a danger signal in brain damage prompt a therapeutic interest to multi-target different purinergic receptors to provide maximal opportunities for neuroprotection.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–207 of 207
Grygorowicz, T., Sulejczak, D., & Strużyńska, L. (2011) · Acta Neurobiologiae Experimentalis · doi:10.55782/ane-2011-1823 · Cited by 27
Takenouchi, T., Iwamaru, Y., Imamura, M., Kato, N., Sugama, S., Fujita, M., Hashimoto, M., Sato, M., OKADA, H. M., Yokoyama, T., et al. (2007) · FEBS Letters · doi:10.1016/j.febslet.2007.05.057 · Cited by 26
Amadio, S., D’Ambrosi, N., Trincavelli, M. L., Tuscano, D., Sancesario, G., Bernardi, G., Martini, C., & Volonté, C. (2005) · Neurochemistry International · doi:10.1016/j.neuint.2005.05.008 · Cited by 25
Traini, C., Pedata, F., Cipriani, S., Mello, T., Galli, A., Giovannini, M. G., Cerbai, F., Volpini, R., Cristalli, G., & Pugliese, A. M. (2011) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2011.07667.x · Cited by 24
Choi, H. K., Ryu, H. J., Kim, J., Jo, S., Choi, H., Song, H., & Kang, T. (2011) · Neurological Sciences · doi:10.1007/s10072-011-0740-z · Cited by 24
GSM mobile phone radiation suppresses brain glucose metabolism
Kwon, M. S., Vorobyev, V., Kännälä, S., et al. (2011) · STM:n Hallinnonalan avoin julkaisuarkisto (Julkari) · doi:10.1038/jcbfm.2011 · Cited by 21
Cosignaling of adenosine and adenosine triphosphate in hypobaric hypoxia-induced hypothermia
Chevrier, C., Bourdon, L., & Canini, F. (2006) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00241.2005 · Cited by 9
Cited by
Disease-Associated Microglia: A Universal Immune Sensor of Neurodegeneration
Deczkowska, A., Keren-Shaul, H., Weiner, A., Colonna, M., Schwartz, M., & Amit, I. (2018) · Cell · doi:10.1016/j.cell.2018.05.003 · Cited by 1,474
How does adenosine control neuronal dysfunction and neurodegeneration?
Cunha, R. A. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13724 · Cited by 441
Self-citationPurinergic Signalling: Therapeutic Developments
Burnstock, G. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00661 · Cited by 398
NLRP3 inflammasome-driven pathways in depression: clinical and preclinical findings
Kaufmann, F. N., Costa, A. P., Ghisleni, G., Diaz, A. P., Rodrigues, A. L. S., Peluffo, H., & Kaster, M. P. (2017) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2017.03.002 · Cited by 370
Microglia in CNS development: Shaping the brain for the future
Mosser, C.-A., Baptista, S., Arnoux, I., & Audinat, E. (2017) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2017.01.002 · Cited by 268
Metadata
- Authors
- Rodrigues, R. J., Tomé, A. R., & Cunha, R. A.
- Venue
- Frontiers in Neuroscience
- Publisher
- Frontiers Media SA
- Published
- 2015-04-28
- Volume
- 9
- Pages
- 148-148
- ISSN
- 1662-453X (ISSN-L)
- OpenAlex
- W1985611042
- Cited by
- 259
- References
- 207
- FWCI
- 22.92
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.